A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Hoffmann, Markus, Kleine-Weber, Hannah, Pöhlmann, Stefan·2020·Molecular Cell

Cited by (1,004)

Items 701–800 of 1,004

  1. Travel-driven emergence and spread of SARS-CoV-2 lineage B.1.620 with multiple VOC-like mutations and deletions in Europe
    Dudas, Gytis, Hong, Samuel L., Potter, Barney, Calvignac-Spencer, Sébastien, Niatou-Singa, Frédéric S., Tombolomako, Thais B., Fuh-Neba, Terence, Vickos, Ulrich, Ulrich, Markus, Leendertz, Fabian H. et al. · 2021
  2. SARS-CoV-2: An Update on Genomics, Risk Assessment, Potential Therapeutics and Vaccine Development
    Iqra Mehmood, Munazza Ijaz, Sajjad Ahmad, Temoor Ahmed, Amna Bari, Asma Abro, Khaled S. Allemailem, Ahmad Almatroudi, Muhammad Tahir ul Qamar · 2021 · International Journal of Environmental Research and Public Health
  3. Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection
    Congshan Jiang, Xiaowei Li, Changrong Ge, Yuanyuan Ding, Tao Zhang, Shuai Cao, Liesu Meng, Shemin Lu · 2021 · Journal of Pharmaceutical Analysis
  4. Viral Prefusion Targeting Using Entry Inhibitor Peptides: The Case of SARS-CoV-2 and Influenza A virus
    Yasaman Behzadipour, Shiva Hemmati · 2022 · International Journal of Peptide Research and Therapeutics
  5. Optimization of SARS-CoV-2 Spike Protein Expression in the Silkworm and Induction of Efficient Protective Immunity by Inoculation With Alum Adjuvants
    Akitsu Masuda, Jae Man Lee, Takeshi Miyata, Hiroaki Mon, Keita Sato, Kosuke Oyama, Yasuteru Sakurai, Jiro Yasuda, Daisuke Takahashi, Tadashi Ueda et al. · 2022 · Frontiers in Immunology
  6. Exosomes and COVID-19: challenges and opportunities
    Ghader Babaei, Nasrin Zare, Ainaz Mihanfar, Mohammad Hassan Khadem Ansari · 2022 · Comparative Clinical Pathology
  7. The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2
    Gary Thomas, Frédéric Couture, Anna Kwiatkowska · 2022 · International Journal of Molecular Sciences
  8. Antibody-mediated immunity to SARS-CoV-2 spike
    John M. Errico, Lucas J. Adams, Daved H. Fremont · 2022 · Advances in immunology
  9. Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection
    Martha Sedegah, Chad K. Porter, Emilie Goguet, Harini D. Ganeshan, María Belmonte, Jun Huang, Arnel D. Belmonte, Sandra Inoue, Neda Acheampong, Allison M. W. Malloy et al. · 2022 · PLoS ONE
  10. SLiM-binding pockets: an attractive target for broad-spectrum antivirals
    Leandro Simonetti, Jakob Nilsson, Gerald M. McInerney, Ylva Ivarsson, Norman E. Davey · 2023 · Trends in Biochemical Sciences
  11. A Multiplexed SERS Microassay for Accurate Detection of SARS-CoV-2 and Variants of Concern
    Courtney Vedelago, Junrong Li, Kym Lowry, Christopher B. Howard, Alain Wuethrich, Matt Trau · 2023 · ACS Sensors
  12. The ACE2 receptor accelerates but is not biochemically required for SARS-CoV-2 membrane fusion
    Marcos Cervantes, Tobin Hess, Giorgio Gianini Morbioli, Anjali Sengar, Peter M. Kasson · 2023 · Chemical Science
  13. Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2
    Fang‐Ju Cheng, Chien‐Yi Ho, Tzong‐Shiun Li, Yeh Chen, Yi‐Lun Yeh, Ya-Ling Wei, Thanh Kieu Huynh, Bo‐Rong Chen, Hung-Yu Ko, Chen-Si Hsueh et al. · 2023 · Cell & Bioscience
  14. A pathogenic and recombinant infectious bronchitis virus variant (CK/CH/GX/202109) with multiorgan tropism
    Chenyan Wang, Bo Hou · 2023 · Veterinary Research
  15. Sequential glycosylations at the multibasic cleavage site of SARS-CoV-2 spike protein regulate viral activity
    Shengjun Wang, Wei Ran, Lingyu Sun, Qingchi Fan, Yuanqi Zhao, Bowen Wang, Jinghong Yang, Yuqi He, Ying Ta Wu, Yuanyuan Wang et al. · 2024 · Nature Communications
  16. Impact of Comorbidities on SARS-CoV-2 Viral Entry-Related Genes
    Joshua D. Breidenbach, Prabhatchandra R. Dube, Subhanwita Ghosh, Belal Abdullah, Nikolaï N. Modyanov, Deepak K Malhotra, Lance D. Dworkin, Steven T. Haller, David J. Kennedy · 2020 · Journal of Personalized Medicine
  17. Mesenchymal Stem Cells and Their Extracellular Vesicles: A Potential Game Changer for the COVID-19 Crisis
    Dina Hamada Kassem, Mohamed Mostafa Kamal · 2020 · Frontiers in Cell and Developmental Biology
  18. Osmotic Adaptation by Na+-Dependent Transporters and ACE2: Correlation with Hemostatic Crisis in COVID-19
    Danah Muhanna, Shanvanth R. Arnipalli, Shashi Bhushan Kumar, Ouliana Ziouzenkova · 2020 · Biomedicines
  19. Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy
    Amirmasoud Rayati Damavandi, Razieh Dowran, Sarah Al Sharif, Fatah Kashanchi, Reza Jafari · 2022 · Medical Microbiology and Immunology
  20. Could a Lower Toll-like Receptor (TLR) and NF-κB Activation Due to a Changed Charge Distribution in the Spike Protein Be the Reason for the Lower Pathogenicity of Omicron?
    Ralf Kircheis, Oliver Planz · 2022 · International Journal of Molecular Sciences
  21. SARS-CoV-2 variants Alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant
    Larissa Laine, Marika Skön, Elina Väisänen, Ilkka Julkunen, Pamela Österlund · 2022 · Frontiers in Immunology
  22. Strategies for the Management of Spike Protein-Related Pathology
    Matthew T. J. Halma, Christof Plothe, Paul Ellis Marik, Theresa Anne Lawrie · 2023 · Microorganisms
  23. SARS-CoV-2 Spike S1 glycoprotein is a TLR4 agonist, upregulates ACE2 expression and induces pro-inflammatory M 1 macrophage polarisation
    Mohamed M. Aboudounya, Mark Holt, Richard J. Heads · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  24. A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2
    Mohammed A. Rohaim, Muhammad Munir · 2020 · Vaccines
  25. New Consensus pattern in Spike CoV-2: potential implications in coagulation process and cell–cell fusion
    Silvia Buonvino, Sonia Melino · 2020 · Cell Death Discovery
  26. Drug discovery and development targeting the life cycle of SARS-CoV-2
    Haixia Su, Yechun Xu, Hualiang Jiang · 2021 · Fundamental Research
  27. Update in COVID-19 2020
    Sanjay Haresh Chotirmall, Lindsay M. Leither, Başak Çoruh, Louisa Chan, Anthony M. Joudi, Samuel Morris Brown, Benjamin David Singer, Nitin Seam · 2021 · American Journal of Respiratory and Critical Care Medicine
  28. Molecular Level Dissection of Critical Spike Mutations in SARS‐CoV‐2 Variants of Concern (VOCs): A Simplified Review
    Nilesh Joshi, Adish Tyagi, Sandeep Nigam · 2021 · ChemistrySelect
  29. Insights into COVID-19 Delta variant (B.1.617.2)
    Angel Yun-Kuan Thye, Ke-Yan Loo, Kyle Bond Chene Tan, Jenny May-Sim Lau, Vengadesh Letchumanan · 2021 · Progress In Microbes & Molecular Biology
  30. A rigorous framework for detecting SARS-CoV-2 spike protein mutational ensemble from genomic and structural features
    Saman Fatihi, Surabhi Rathore, Ankit Kumar Pathak, Deepanshi Gahlot, Mitali Mukerji, Nidhi Jatana, Lipi Thukral · 2021 · Current Research in Structural Biology
  31. Organoid Models of SARS-CoV-2 Infection: What Have We Learned about COVID-19?
    Bang M. Tran, Georgia Deliyannis, Abderrahman Hachani, Linda Earnest, Joseph Torresi, Elizabeth Vincan · 2022 · Organoids
  32. A highly immunogenic live-attenuated vaccine candidate prevents SARS-CoV-2 infection and transmission in hamsters
    Xiaofeng Li, Zhen Cui, Hang Fan, Qi Chen, Lei Cao, Hongying Qiu, Nana Zhang, Yan‐Peng Xu, Rongrong Zhang, Chao Hui ZHOU et al. · 2022 · The Innovation
  33. Developing Small-Molecule Inhibitors of Protein-Protein Interactions Involved in Viral Entry as Potential Antivirals for COVID-19
    Péter Buchwald · 2022 · Frontiers in Drug Discovery
  34. NOTCH signaling in COVID-19: a central hub controlling genes, proteins, and cells that mediate SARS-CoV-2 entry, the inflammatory response, and lung regeneration
    Piyush Baindara, Md Bodruzzaman Sarker, Alexander Earhart, Santi M. Mandal, Adam G. Schrum · 2022 · Frontiers in Cellular and Infection Microbiology
  35. Promising natural products against SARS‐CoV ‐2: Structure, function, and clinical trials
    Yan Zhao, Shanshan Deng, Yujiao Bai, Jinlin Guo, Guoyin Kai, Xinhe Huang, Xu Jia · 2022 · Phytotherapy Research
  36. Effects of mild obesity on outcomes in Japanese patients with COVID-19: a nationwide consortium to investigate COVID-19 host genetics
    Ho Lee, Shotaro Chubachi, Ho Namkoong, Hiromu Tanaka, Shiro Otake, Kensuke Nakagawara, Atsuho Morita, Takahiro Fukushima, Mayuko Watase, Tatsuya Kusumoto et al. · 2022 · Nutrition and Diabetes
  37. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants
    Stacy Gellenoncourt, Nell Saunders, Rémy Robinot, Lucas Auguste, Maaran Michael Rajah, Jérôme Kervevan, Raphaël Jeger‐Madiot, Isabelle Staropoli, Cyril Planchais, Hugo Mouquet et al. · 2022 · Journal of Virology
  38. Analyzing master regulators and scRNA-seq of COVID-19 patients reveals an underlying anti-SARS-CoV-2 mechanism of ZNF proteins
    Shijie Qin, Weijun Xu, Canbiao Wang, Sizhu Jiang, Wei Dai, Yang Yang, Jiawei Shen, Ping Jin, Fei Ma, Xinyi Xia · 2021 · Briefings in Bioinformatics
  39. A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter
    Wen-Yang Tsai, Lauren Lei Ching, Szu‐Chia Hsieh, Marian E. Melish, Vivek R. Nerurkar, Wei‐Kung Wang · 2021 · Emerging Microbes & Infections
  40. A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells
    Barbara Storti, Paola Quaranta, Cristina Di Primio, Nicola Clementi, Nicasio Mancini, Elena Criscuolo, Pietro Giorgio Spezia, Vittoria Carnicelli, Giulia Lottini, Emanuele Paolini et al. · 2021 · Computational and Structural Biotechnology Journal
  41. SARS-CoV-2 S1 Protein Induces Endolysosome Dysfunction and Neuritic Dystrophy
    Gaurav Datta, Nicole Miller, Peter W. Halcrow, Nabab Khan, Timothy Colwell, Jonathan D. Geiger, Xuesong Chen · 2021 · Frontiers in Cellular Neuroscience
  42. Can Panax ginseng help control cytokine storm in COVID-19?
    Jong Hee Choi, Young Hyun Lee, Tae Woo Kwon, Seong‐Gyu Ko, Seung-Yeol Nah, Ik‐Hyun Cho · 2022 · Journal of Ginseng Research
  43. Dichlorophenylpyridine-Based Molecules Inhibit Furin through an Induced-Fit Mechanism
    Sven O. Dahms, Gisela Schnapp, Martin Winter, Frank H. Büttner, Marco Schlepütz, Christian Gnamm, Alexander Pautsch, Hans Brandstetter · 2022 · ACS Chemical Biology
  44. The Endolysosomal System: The Acid Test for SARS-CoV-2
    Daniella Cesar-Silva, Filipe Santos Pereira-Dutra, Ana L.M. Giannini, Cecília J. G. de Almeida · 2022 · International Journal of Molecular Sciences
  45. Computational prediction of the molecular mechanism of statin group of drugs against SARS-CoV-2 pathogenesis
    Dipanjan Ghosh, Debabrata Ghosh Dastidar, Kamalesh Roy, Arnab Ghosh, Debanjan Mukhopadhyay, Nilabja Sikdar, Nidhan K. Biswas, Gopal Chakrabarti, Amlan Kumar Das · 2022 · Scientific Reports
  46. Transmembrane Protease Serine 2 Proteolytic Cleavage of the SARS-CoV-2 Spike Protein: A Mechanistic Quantum Mechanics/Molecular Mechanics Study to Inspire the Design of New Drugs To Fight the COVID-19 Pandemic
    Luís M. C. Teixeira, João T. S. Coimbra, Maria João Ramos, Pedro Alexandrino Fernandes · 2022 · Journal of Chemical Information and Modeling
  47. Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection
    Oleksandr Dmytrenko, Kory J. Lavine · 2022 · Viruses
  48. Genome‐wide association analysis of COVID‐19 mortality risk in SARS‐CoV‐2 genomes identifies mutation in the SARS‐CoV‐2 spike protein that colocalizes with P.1 of the Brazilian strain
    Georg Hahn, Chloe M. Wu, Sanghun Lee, Sharon Marie Lutz, Surender Khurana, Lindsey Robert Baden, Sebastien Haneuse, Dandi Qiao, Julian Hecker, Dawn Lisa DeMeo et al. · 2021 · Genetic Epidemiology
  49. When the Dust Has Settled: Calculation of Binding Affinities from First Principles for SARS-CoV-2 Variants with Quantitative Accuracy
    Emma Goulard Coderc de Lacam, Marharyta Blazhynska, Haochuan Chen, James C. Gumbart, Christophe J. Chipot · 2022 · Journal of Chemical Theory and Computation
  50. Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics
    Jimena Pérez‐Vargas, Tirosh Shapira, Andrea D. Olmstead, Ivan Villanueva, Connor A.H. Thompson, Siobhan Ennis, Guang Gao, Joshua De Guzman, David E. Williams, Meng Wang et al. · 2022 · Antiviral Research
  51. The role of regulatory T cells and follicular T helper cells in HBV infection
    Nengqi Lin, Wei Hua Yin, H. I. Miller, Maria G. Byazrova, Andrés A. Herrada, Kamel Benlagha, Pamela P. W. Lee, Fei Guan, Jiahui Lei, Quan Gong et al. · 2023 · Frontiers in Immunology
  52. COVID-19 mutations: An overview
    Malay S. Sarkar, Irappa Madabhavi · 2024 · World Journal of Methodology
  53. Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts
    Robert H. Bortz, Catalina Florez, Ethan Laudermilch, Ariel S. Wirchnianski, Gorka Lasso, Ryan J. Malonis, George Ivanov Georgiev, Olivia Vergnolle, Natalia G. Herrera, Nicholas C. Morano et al. · 2021 · mSphere
  54. Dysbalance of ACE2 levels – a possible cause for severe COVID ‐19 outcome in COPD
    Elisabeth Fließer, Anna Birnhuber, Leigh Matthew Marsh, Elisabeth Gschwandtner, Walter Klepetko, Horst Olschewski, Grażyna Kwapiszewska · 2021 · The Journal of Pathology Clinical Research
  55. Tofacitinib therapy intercepts macrophage metabolic reprogramming instigated by SARS‐CoV‐2 Spike protein
    Karol Palasiewicz, Sadiq Umar, Bianca Romay, Ryan K. Zomorrodi, Shiva Shahrara · 2021 · European Journal of Immunology
  56. OFF-State-Specific Inhibition of the Proprotein Convertase Furin
    Sven O. Dahms, Tanja Haider, Gerhard Klebe, Torsten Steinmetzer, Hans Brandstetter · 2021 · ACS Chemical Biology
  57. Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP)
    Arjun Sweet, Nicole M. André, Alison E. Stout, Beth Nicole Licitra, Gary R. Whittaker · 2022 · Viruses
  58. Probable human origin of the SARS-CoV-2 polybasic furin cleavage motif
    Antonio R. Romeu · 2023 · BMC Genomic Data
  59. COVID-19, Vascular Endothelial Growth Factor (VEGF) and Iodide
    Mika Turkia · 2020 · SSRN Electronic Journal
  60. Immunogenicity of novel mRNA COVID-19 vaccine MRT5500 in mice and non-human primates
    Kalnin, Kirill V., Plitnik, Timothy, Kishko, Michael, Zhang, Jinrong, Zhang, Donghui, Beauvais, Adrien, Anosova, Natalie G., Tibbitts, Timothy, DiNapoli, Joshua M., Huang, Po-Wei D. et al. · 2020
  61. Clinical application of single‐cell RNA sequencing in disease and therapy
    Aisha Shigna Nadukkandy, Sowmiya Kalaiselvan, Lin Lin, Yonglun Luo · 2025 · Clinical and Translational Medicine
  62. Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants
    Chiara Elisabetta Cotroneo, Nunzia Mangano, Tommaso Antonio Dragani, Francesca Colombo · 2021 · European Journal of Human Genetics
  63. Kann SARS-CoV-2 das Auge infizieren? – Ein Überblick über den Rezeptorstatus in okularem Gewebe
    Sven Schnichels, Jens Martin Rohrbach, Tarek Bayyoud, Sebastian Thaler, Focke Ziemssen, José Hurst · 2020 · Der Ophthalmologe
  64. Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression
    Stephanie A. Sheehan, Kelly L. Hamilton, Edward P. Retzbach, Premalatha Balachandran, Harini Krishnan, Paola Leone, Moisés López-González, Shraddha Suryavanshi, Pradeep Kumar, Riccardo Russo et al. · 2021 · Experimental Cell Research
  65. Reducing SARS-CoV-2 pathological protein activity with small molecules
    Donata Pluskota‐Karwatka, Marcin Hoffmann, Jan Barciszewski · 2021 · Journal of Pharmaceutical Analysis
  66. Perspectives and potential approaches for targeting neuropilin 1 in SARS-CoV-2 infection
    Svetlana P. Chapoval, Achsah Dorsey Keegan · 2021 · Molecular Medicine
  67. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling
    Elena I. Frolova, Oksana Palchevska, Tetyana Lukash, Francisco de Borja Pérez Domínguez, William J. Britt, Ilya V. Frolov · 2022 · Journal of Virology
  68. Molecular mechanisms involved in anosmia induced by SARS-CoV-2, with a focus on the transmembrane serine protease TMPRSS2
    Ali Karimian, Mohaddeseh Behjati, Mohammad Karimian · 2022 · Archives of Virology
  69. SARS-CoV-2 Spike-Mediated Entry and Its Regulation by Host Innate Immunity
    Shi Yu, Huina Hu, Qiangyun Ai, Rong Bai, Kaixiong Ma, Minmin Zhou, Shaobo Wang · 2023 · Viruses
  70. Cathepsins and SARS‐CoV‐2 infection: From pathogenic factors to potential therapeutic targets
    Shuxuan Zhao, Muzhou Jiang, Hong Qing, Junjun Ni · 2023 · British Journal of Pharmacology
  71. Potential ocular and systemic COVID-19 prophylaxis approaches for healthcare professionals
    Sharon D’Souza, Rohit Shetty, Vaitheeswaran Ganesan Lalgudi, Pooja M Khamar, Krati Gupta, Swaminathan Sethu, Archana Nair, Santosh G Honavar, Arkasubhra Ghosh · 2020 · Indian Journal of Ophthalmology
  72. Anti-inflammatory drugs and the renin-angiotensin-aldosterone system: Current knowledge and potential effects on early SARS-CoV-2 infection
    Iris Louise N. Cabbab, Rafael Vincent M. Manalo · 2020 · Virus Research
  73. Serological antibody testing in the COVID-19 pandemic: their molecular basis and applications
    Jiayue-Clara Jiang, Yan Zhang · 2020 · Biochemical Society Transactions
  74. Implications of Vitamin D Research in Chickens can Advance Human Nutrition and Perspectives for the Future
    Matthew F Warren, Kimberly A. Livingston · 2021 · Current Developments in Nutrition
  75. The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications
    Priya Veluswamy, Max Wacker, Dimitrios Stavridis, Thomas Reichel, Hendrik Schmidt, Maximilian Philipp Scherner, Jens Wippermann, Guido Michels · 2021 · Viruses
  76. Seq12, Seq12m, and Seq13m, peptide analogues of the spike glycoprotein shows antiviral properties against SARS-CoV-2: An in silico study through molecular docking, molecular dynamics simulation, and MM-PB/GBSA calculations
    Kunal Dutta, Ammar D. Elmezayen, Anas Al-Obaidi, Wei Zhu, Olga V. Morozova, Sergey Shityakov, Ibrahim Khalifa · 2021 · Journal of Molecular Structure
  77. Adipose tissue dysfunction and MAFLD in obesity on the scene of COVID-19
    Adryana Cordeiro, Amanda Ribamar, Andréa Ramalho · 2021 · Clinics and Research in Hepatology and Gastroenterology
  78. Animal models for SARS-CoV-2 and SARS-CoV-1 pathogenesis, transmission and therapeutic evaluation
    Udhaya Bharathy Saravanan, Mayurikaa Namachivayam, Rajesh Jeewon, Jian‐Dong Huang, Siva Sundara Kumar Durairajan · 2022 · World Journal of Virology
  79. FURIN gene variants (rs6224/rs4702) as potential markers of death and cardiovascular traits in severe COVID‐19
    Eliécer Coto, Guillermo M. Albaiceta, Laura Amado‐Rodríguez, Marta María García Clemente, Elías Cuesta‐Llavona, Daniel Vázquez‐Coto, Belén Alonso, Sara Iglesias, Santiago Melón, Marta Elena Álvarez‐Argüelles et al. · 2022 · Journal of Medical Virology
  80. Natural killer cell exhaustion in SARS-CoV-2 infection
    Janet Gallardo‐Zapata, Carmen Maldonado‐Bernal · 2022 · Innate Immunity
  81. The nervous system during COVID ‐19: Caught in the crossfire
    Nick R. Natale, John R. Lukens, William A. Petri · 2022 · Immunological Reviews
  82. Thromboembolic Disease and Cardiac Thrombotic Complication in COVID-19: A Systematic Review
    Francesco Nappi, Pierluigi Nappi, Ivancarmine Gambardella, Sanjeet Singh Avtaar Singh · 2022 · Metabolites
  83. Proviral role of human respiratory epithelial cell‐derived small extracellular vesicles in SARS‐CoV‐2 infection
    François Berry, Margot Morin‐Dewaele, Amene Majidipur, Thibaud Jamet, Sophie Bartier, Eva Ignjatovic, Donatella Toniutti, Jeanne Gaspar Lopes, Pascale Soyeux, Pascale Maillé et al. · 2022 · Journal of Extracellular Vesicles
  84. Design of Specific Primer Sets for the Detection of SARS-CoV-2 Variants of Concern B.1.1.7, B.1.351, P.1, B.1.617.2 using Artificial Intelligence
    Carmina Angelica Perez-Romero, Alberto Paolo Tonda, Lucero Mendoza‐Maldonado, Etienne Coz, Patrick Tabeling, Jessica Vanhomwegen, Eric Claassen, Johan Garssen, Aletta D. Kraneveld, Alejandro Lopez‐Rincon · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  85. SARS-CoV-2 and the Secret of the Furin Site
    Antonio R. Romeu, Enric Ollé · 2021 · Preprints.org
  86. Animal Models for COVID-19: More to the Picture Than ACE2, Rodents, Ferrets, and Non-human Primates. A Case for Porcine Respiratory Coronavirus and the Obese Ossabaw Pig
    Peter M. H. Heegaard, Michael S. Sturek, Mouhamad Alloosh, Graham J. Belsham · 2020 · Frontiers in Microbiology
  87. Use of nanotechnology in combating coronavirus
    Saee Gharpure, Balaprasad G Ankamwar · 2021 · 3 Biotech
  88. Lung-Centric Inflammation of COVID-19: Potential Modulation by Vitamin D
    Hana M. A. Fakhoury, Peter R. Kvietys, Ismail Mohammed Shakir, Hashim Shams, William Burgess Grant, Khaled Manae AlKattan · 2021 · Nutrients
  89. T Lymphocytes as Targets for SARS-CoV-2
    Е. М. Куклина · 2022 · Biochemistry (Moscow)
  90. Increased TRIM31 gene expression is positively correlated with SARS-CoV-2 associated genes TMPRSS2 and TMPRSS4 in gastrointestinal cancers
    Mehmet Arda Temena, Ahmet Acar · 2022 · Scientific Reports
  91. COVID-19 and diabetes in children
    Sara Prosperi, Francesco Chiarelli · 2022 · Annals of Pediatric Endocrinology & Metabolism
  92. Antigen epitopes of animal coronaviruses: a mini-review
    Mingjun Su, Guanghui Zheng, Xiangwen Xu, Houhui Song · 2023 · Animal Diseases
  93. Ultrastructural study confirms the formation of single and heterotypic syncytial cells in bronchoalveolar fluids of COVID-19 patients
    Shikha Chaudhary, Ravi Prakash Yadav, Shailendra Kumar, Subhash Chandra Yadav · 2023 · Virology Journal
  94. Host Cell Membrane Capture by the SARS-CoV-2 Spike Protein Fusion Intermediate
    Rui Su, Jin Zeng, Tara C. Marcink, Matteo Porotto, Anne Moscona, Ben O’Shaughnessy · 2023 · ACS Central Science
  95. Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages
    Enya Qing, Tom Gallagher · 2023 · mBio
  96. Comparison of treatment of COVID-19 with inhaled bromhexine, higher doses of colchicine and hymecromone with WHO-recommended paxlovid, molnupiravir, remdesivir, anti-IL-6 receptor antibodies and baricitinib
    Vanio Mitev · 2023 · Pharmacia
  97. Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives
    Yikan Sun, Can Wang, Peiquan Lin, Lei Hu, Jing Ye, Zhigang Gao, Ru Lin, Haomin Li, Qiang Shu, Lisu Huang et al. · 2024 · World Journal of Pediatrics
  98. TMPRSS2 as a Key Player in Viral Pathogenesis: Influenza and Coronaviruses
    Gilmara Barros de Lima, Everton Nencioni, Fábio Thimoteo, Camila Perea, Rafaela Fuzaro Alves Pinto, Sergio Daishi Sasaki · 2025 · Biomolecules
  99. Potential interactions of SARS‐CoV‐2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues
    Paulo Ricardo Criado, Thaís Pincelli, Roberta Fachini Jardim Criado, Beatrice Martinez Zugaib Abdalla, Walter Belda · 2020 · Experimental Dermatology
  100. Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients
    Tales Lyra de Oliveira, Igor Santana de Melo, Léia Cardoso-Sousa, Igor Andrade Santos, Mohamad Bassim El Zoghbi, Caroline Gusson Shimoura, Renata Pereira Georjutti, Olagide Wagner de Castro, Luíz Ricardo Goulart, Ana Carolina Gomes Jardim et al. · 2020 · Frontiers in Physiology